NasdaqCM - Nasdaq Real Time Price USD

Catalyst Pharmaceuticals, Inc. (CPRX)

Compare
21.92
-0.88
(-3.86%)
At close: January 10 at 4:00:01 PM EST
21.74
-0.18
(-0.82%)
After hours: 7:59:44 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
460,482.00
398,204.00
214,203.00
140,833.00
119,073.00
Cost of Revenue
63,011.00
51,967.00
34,393.00
21,884.00
17,039.00
Gross Profit
397,471.00
346,237.00
179,810.00
118,949.00
102,034.00
Operating Expense
223,498.00
259,425.00
77,972.00
66,564.00
60,731.00
Operating Income
173,973.00
86,812.00
101,838.00
52,385.00
41,303.00
Other Income Expense
6,620.00
7,699.00
2,881.00
282.00
587.00
Pretax Income
188,789.00
94,511.00
104,719.00
52,667.00
41,890.00
Tax Provision
45,992.00
23,101.00
21,640.00
13,185.00
-33,093.00
Net Income Common Stockholders
142,797.00
71,410.00
83,079.00
39,482.00
74,983.00
Diluted NI Available to Com Stockholders
142,797.00
71,410.00
83,079.00
39,482.00
74,983.00
Basic EPS
1.25
0.67
0.80
0.38
0.72
Diluted EPS
1.18
0.63
0.75
0.37
0.71
Basic Average Shares
115,161.97
106,279.74
103,374.61
103,379.35
103,512.91
Diluted Average Shares
121,829.51
113,753.15
111,375.63
107,795.59
106,242.27
Total Operating Income as Reported
173,973.00
86,812.00
101,838.00
52,385.00
41,303.00
Total Expenses
286,509.00
311,392.00
112,365.00
88,448.00
77,770.00
Net Income from Continuing & Discontinued Operation
142,797.00
71,410.00
83,079.00
39,482.00
74,983.00
Normalized Income
143,613.14
71,410.00
83,079.00
39,482.00
74,983.00
EBIT
173,973.00
86,812.00
101,838.00
52,385.00
41,303.00
EBITDA
211,432.00
119,693.00
103,077.00
52,577.00
41,395.00
Reconciled Cost of Revenue
62,644.00
51,651.00
34,252.00
21,692.00
17,039.00
Reconciled Depreciation
37,459.00
32,881.00
1,239.00
192.00
92.00
Net Income from Continuing Operation Net Minority Interest
142,797.00
71,410.00
83,079.00
39,482.00
74,983.00
Total Unusual Items Excluding Goodwill
-1,079.00
--
--
--
--
Total Unusual Items
-1,079.00
--
--
--
--
Normalized EBITDA
212,511.00
119,693.00
103,077.00
52,577.00
41,395.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-262.86
--
--
--
--
12/31/2020 - 11/8/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIR Vir Biotechnology, Inc.
12.10
-3.04%
 
SILO Silo Pharma, Inc.
1.7700
+3.51%
 
HOTH Hoth Therapeutics, Inc.
1.9000
0.00%
 
SANA Sana Biotechnology, Inc.
3.6600
-14.88%
 
SPRC SciSparc Ltd.
0.8149
+1.03%
 
IMRX Immuneering Corporation
2.0700
+3.50%
 
ABSI Absci Corporation
2.8550
-11.34%
 
BLRX BioLineRx Ltd.
0.1429
+0.21%
 
CDT Conduit Pharmaceuticals Inc.
0.1233
+50.37%
 
MBIO Mustang Bio, Inc.
0.2566
+15.38%